Symptoms of Sjögren's Syndrome-Associated Distal Renal Tubular Acidosis
Patients with Sjögren's syndrome-associated distal renal tubular acidosis (dRTA) typically present with severe hypokalemia causing muscle weakness or flaccid quadriparesis, often accompanied by metabolic acidosis, and may or may not have the classic sicca symptoms (dry eyes and mouth) at initial presentation.
Primary Clinical Manifestations
Neuromuscular Symptoms (Most Dramatic Presentation)
- Acute flaccid quadriparesis or generalized muscle weakness due to severe hypokalemia 1, 2, 3
- Episodes can be recurrent and life-threatening 3
- Lower limb weakness may be the predominant initial complaint 2
- Dysphagia can occur in severe cases 3
Electrolyte and Acid-Base Disturbances
- Severe hypokalemia (the hallmark finding causing most acute symptoms) 4, 1, 2, 3, 5
- Normal anion gap (hyperchloremic) metabolic acidosis 4, 1, 2, 3, 5
- Positive urine anion gap indicating renal potassium wasting 4, 3
- Inappropriately alkaline urine pH despite systemic acidosis 2, 3
Renal Manifestations
- Nephrocalcinosis (calcium deposition in kidneys) 5
- Mild proteinuria 4
- Progressive chronic kidney disease if untreated 4
- Risk of nephrolithiasis 4
Sicca Symptoms (May Be Absent Initially)
A critical pitfall: dRTA can precede or occur without classic sicca symptoms 1, 2, 3. When present:
Important Clinical Pearls
The absence of sicca symptoms does not exclude Sjögren's syndrome when dRTA is present. Multiple recent case reports demonstrate that hypokalemic paralysis from dRTA can be the initial and sole manifestation of primary Sjögren's syndrome 1, 2, 3. This represents a diagnostic trap where clinicians may miss the underlying autoimmune disease if they expect typical dry eyes and mouth.
The mechanism involves autoimmune targeting of distal nephron acid-base transporters (H⁺-ATPase and anion exchanger 1), which can cause significant tubular dysfunction even without histologic evidence of tubulointerstitial nephritis on renal biopsy 4. This functional defect explains why patients develop severe metabolic derangements despite minimal inflammatory changes.
Diagnostic Workup Findings
When evaluating these patients, expect:
- Positive ANA (often high titer, e.g., 1:1280) 4
- Anti-Ro/SSA antibodies (highly specific) 4, 1, 2, 3
- Anti-La/SSB antibodies 1, 2, 3
- Abnormal Schirmer's test (even without subjective dryness) 1, 3
- Salivary gland biopsy showing lymphocytic infiltration 3
Clinical Course
Patients typically respond rapidly to potassium and bicarbonate supplementation 1, 2, 3, 5, though long-term management requires ongoing electrolyte replacement and monitoring for disease progression. Without treatment, complications include life-threatening arrhythmias from hypokalemia, nephrolithiasis, and progressive renal dysfunction 4.